Literature DB >> 21336691

Sp1 collagen I A1 polymorphism in women with stress urinary incontinence.

Dimos Sioutis1, Emmanuel Economou, Irene Lambrinoudaki, Vasilios Tsamadias, Maria Creatsa, Angelos Liapis.   

Abstract

INTRODUCTION AND HYPOTHESIS: Stress urinary incontinence (SUI) is in part attributed to qualitative and quantitative changes in connective tissue of the urogenital tract. We examined the association of collagen type I a1 (COLIA 1) Sp1 polymorphism with the risk of SUI.
METHODS: Forty-five postmenopausal women suffering from urodynamically verified SUI (study group) were compared to 45 healthy volunteers (control). DNA was extracted from peripheral blood. The genotyping concerning the type 1 a1 collagen gene Sp1 polymorphism was performed with polymerase chain reaction.
RESULTS: The polymorphic T allele was overrepresented in the SUI patients (63.2% versus 36.8%, p = 0.016). Odds ratio for SUI in women harboring the T allele was 2.19 (95% CI 1.149-4.176) compared to women with the wild-type genotype.
CONCLUSIONS: The COLIA1 Sp1 polymorphism is associated with increased prevalence of stress urinary incontinence in postmenopausal women.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21336691     DOI: 10.1007/s00192-011-1372-9

Source DB:  PubMed          Journal:  Int Urogynecol J        ISSN: 0937-3462            Impact factor:   2.894


  22 in total

1.  Good urodynamic practices: uroflowmetry, filling cystometry, and pressure-flow studies.

Authors:  Werner Schäfer; Paul Abrams; Limin Liao; Anders Mattiasson; Francesco Pesce; Anders Spangberg; Arthur M Sterling; Norman R Zinner; Philip van Kerrebroeck
Journal:  Neurourol Urodyn       Date:  2002       Impact factor: 2.696

2.  Histology of the connection between the vagina and levator ani muscles. Implications for urinary tract function.

Authors:  J O DeLancey; R A Starr
Journal:  J Reprod Med       Date:  1990-08       Impact factor: 0.142

3.  Association of collagen type I alpha1 (COLIA1) Sp1 polymorphism with osteoporotic fracture in Caucasian post-menopausal women: a meta-analysis.

Authors:  G-R Ji; M Yao; C-Y Sun; L Zhang; Z Han
Journal:  J Int Med Res       Date:  2009 Nov-Dec       Impact factor: 1.671

4.  Changes in the quantity of collagen type I in women with genuine stress incontinence.

Authors:  A Liapis; P Bakas; A Pafiti; D Hassiakos; M Frangos-Plemenos; G Creatsas
Journal:  Urol Res       Date:  2000-10

5.  Reduced bone density and osteoporosis associated with a polymorphic Sp1 binding site in the collagen type I alpha 1 gene.

Authors:  S F Grant; D M Reid; G Blake; R Herd; I Fogelman; S H Ralston
Journal:  Nat Genet       Date:  1996-10       Impact factor: 38.330

6.  COL1A1 Sp1-binding site polymorphism as a risk factor for genital prolapse.

Authors:  Andrea Moura Rodrigues; Manoel João Batista Castello Girão; Ismael Dale Cotrim Guerreiro da Silva; Marair Gracio Ferreira Sartori; Karina de Falco Martins; Rodrigo de Aquino Castro
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2008-06-13

7.  Periurethral connective tissue status of postmenopausal women with genital prolapse with and without stress incontinence.

Authors:  Christian Goepel; Lukas Hefler; Hans-Dietrich Methfessel; Heinz Koelbl
Journal:  Acta Obstet Gynecol Scand       Date:  2003-07       Impact factor: 3.636

8.  Polymorphism of a COLIA1 gene Sp1 binding site in Korean women with pelvic organ prolapse.

Authors:  Hye Jin Cho; Hyun Joo Jung; Sei Kwang Kim; Jong Rak Choi; Nam Hoon Cho; Sang Wook Bai
Journal:  Yonsei Med J       Date:  2009-08-19       Impact factor: 2.759

9.  Large-scale evidence for the effect of the COLIA1 Sp1 polymorphism on osteoporosis outcomes: the GENOMOS study.

Authors:  Stuart H Ralston; André G Uitterlinden; Maria Luisa Brandi; Susana Balcells; Bente L Langdahl; Paul Lips; Roman Lorenc; Barbara Obermayer-Pietsch; Serena Scollen; Mariona Bustamante; Lise Bjerre Husted; Alisoun H Carey; Adolfo Diez-Perez; Alison M Dunning; Alberto Falchetti; Elzbieta Karczmarewicz; Marcin Kruk; Johannes P T M van Leeuwen; Joyce B J van Meurs; Jon Mangion; Fiona E A McGuigan; Leonardo Mellibovsky; Francesca del Monte; Huibert A P Pols; Jonathan Reeve; David M Reid; Wilfried Renner; Fernando Rivadeneira; Natasja M van Schoor; Rachael E Sherlock; John P A Ioannidis
Journal:  PLoS Med       Date:  2006-02-21       Impact factor: 11.069

10.  Evaluation and outcome measures in the treatment of female urinary stress incontinence: International Urogynecological Association (IUGA) guidelines for research and clinical practice.

Authors:  G Ghoniem; E Stanford; K Kenton; C Achtari; R Goldberg; T Mascarenhas; M Parekh; K Tamussino; S Tosson; G Lose; E Petri
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2007-11-17
View more
  4 in total

1.  Evaluation of COLIA1-1997 G/T polymorphism as a related factor to genital prolapse.

Authors:  Claudia Cristina Palos; Beatriz Ferreira Timm; Denise de Souza Paulo; Cesar Eduardo Fernandes; Ricardo Peres de Souto; Emerson Oliveira
Journal:  Int Urogynecol J       Date:  2018-11-27       Impact factor: 2.894

2.  Association of collagen type I alpha 1 gene polymorphism with inguinal hernia.

Authors:  S Sezer; N Şimşek; H T Celik; G Erden; G Ozturk; A P Düzgün; F Çoşkun; K Demircan
Journal:  Hernia       Date:  2013-08-08       Impact factor: 4.739

Review 3.  Systematic review and metaanalysis of genetic association studies of urinary symptoms and prolapse in women.

Authors:  Rufus Cartwright; Anna C Kirby; Kari A O Tikkinen; Altaf Mangera; Gans Thiagamoorthy; Prabhakar Rajan; Jori Pesonen; Chris Ambrose; Juan Gonzalez-Maffe; Phillip Bennett; Tom Palmer; Andrew Walley; Marjo-Riitta Järvelin; Chris Chapple; Vik Khullar
Journal:  Am J Obstet Gynecol       Date:  2014-08-08       Impact factor: 8.661

Review 4.  Molecular Processes in Stress Urinary Incontinence: A Systematic Review of Human and Animal Studies.

Authors:  Wilke M Post; Joanna Widomska; Hilde Grens; Marieke J H Coenen; Frank M J Martens; Dick A W Janssen; Joanna IntHout; Geert Poelmans; Egbert Oosterwijk; Kirsten B Kluivers
Journal:  Int J Mol Sci       Date:  2022-03-21       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.